Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?

Schultz-Swarthfigure, CT; McCall, P; Docking, R; Galley, HF; Shelley, B

Shelley, B (corresponding author), Golden Jubilee Natl Hosp, Dept Anaesthesia, Agamemnon St, Glasgow G81 4DY, Lanark, Scotland.

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021; 32 (2): 236

Abstract

OBJECTIVES: Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker that has been implicated in several cardiac pathologies and has be......

Full Text Link